Emergent Biosolutions Inc Stock CINNOBER BOAT
Equities
0IGA
US29089Q1058
Pharmaceuticals
Financials (USD)
Sales 2024 * | 1.02B | Sales 2025 * | 1.14B | Capitalization | 291M |
---|---|---|---|---|---|
Net income 2024 * | -155M | Net income 2025 * | -110M | EV / Sales 2024 * | 0.4 x |
Net Debt 2024 * | 111M | Net Debt 2025 * | 336M | EV / Sales 2025 * | 0.55 x |
P/E ratio 2024 * |
-1.85
x | P/E ratio 2025 * |
-2.64
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.65% |
Latest transcript on Emergent Biosolutions Inc
Managers | Title | Age | Since |
---|---|---|---|
Joseph Papa
CEO | Chief Executive Officer | 68 | Feb. 20 |
Richard Lindahl
DFI | Director of Finance/CFO | 70 | 18-03-25 |
Kelly Warfield
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 22-03-31 |
Marvin White
BRD | Director/Board Member | 61 | 10-05-31 |
Louis Sullivan
BRD | Director/Board Member | 90 | 04-12-31 |
1st Jan change | Capi. | |
---|---|---|
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |